Generated Lymphoblastoid Cell Lines

Overview

About this study

The purpose of this study is to generate lymphoblastoid cell lines (LCLs) from whole blood or peripheral blood mononuclear cells (PBMCs) to serve as models of diseases or as controls.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients with known or suspected genetic disorders.
Patients with disorders where the genetic basis is not known.
Control subjects.

Exclusion Criteria:

Patients with no known genetic disorders.

Eligibility last updated 10/20/22 Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Akhilesh Pandey, M.D., Ph.D.	Open for enrollment	Contact information: Akhilesh Pandey M.D., Ph.D. (507) 293-9564 Pandey.Akhilesh@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Akhilesh Pandey, M.D., Ph.D.

Open for enrollment

Contact information:

Akhilesh Pandey M.D., Ph.D.

(507) 293-9564

Pandey.Akhilesh@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials